(19)
(11) EP 4 823 610 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24828775.7

(22) Date of filing: 12.12.2024
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61P 37/06(2006.01)
A61P 9/00(2006.01)
C07K 16/40(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/40; C07K 2317/76; C07K 2317/565; C07K 2317/567; A61P 9/00; A61P 37/06; A61K 39/3955
(86) International application number:
PCT/EP2024/086050
(87) International publication number:
WO 2025/125501 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.12.2023 EP 23216103

(71) Applicant: Eberhard Karls Universität Tübingen, Medizinische Fakultät
72074 Tübingen (DE)

(72) Inventors:
  • GAWAZ, Meinrad
    72076 Tuebingen (DE)
  • HEINZMANN, David
    72020 Tuebingen (DE)
  • SIGLE, Manuel
    72076 Tuebingen (DE)

(74) Representative: Witte, Weller & Partner Patentanwälte mbB 
Postfach 10 54 62
70047 Stuttgart
70047 Stuttgart (DE)

   


(54) ANTIBODY TARGETING EXTRACELLULAR CYCLOPHILIN A